Illumina, Inc. (ILMN) Stock Price Today
Key Stats
- $28.38BMarket Cap
- -Volume
- HealthSector
- $205.1052W High
- $91.0052W Low
- -Typical Hold Time
- $29.74BEnterprise Value
- -Div Yield
- -Trading Activity
Track Illumina, Inc. (ILMN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Illumina, Inc. has traded between a low of $91 and a high of $205.1, highlighting its annual price range. Buy and sell Illumina, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Most Recent News
Yili hosts sustainability forum at World Dairy Conference, shaping post-2030 dairy industry future.
Yili Group held a sustainability forum on August 2, 2026, during the World Dairy Industry Conference in Hohhot, China, gathering over 200 global leaders to discuss sustainable development in dairy farming beyond 2030. The event highlighted Yili's lea...
Yili hosts global dairy sustainability forum, driving post-2030 green industry goals.
Yili Group organized a Sustainability Forum during the 2026 World Dairy Industry Conference in Hohhot, China, gathering over 200 international leaders to promote sustainable development in the dairy sector beyond 2030. The event highlighted Yili's le...
Halper Sadeh LLC investigates if shareholders of BZH, ACA, SYNA, CRNX get fair deals in recent sales.
Halper Sadeh LLC is investigating whether shareholders of Beazer Homes USA (BZH), Arcosa (ACA), Synaptics (SYNA), and Crinetics Pharmaceuticals (CRNX) are receiving fair treatment in their companies' recent sales. The law firm suspects insiders may g...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.